CSL - Selling And Administration Expenses

Stock Price
97.96
Daily Change
0.70 0.72%
Monthly
-28.78%
Yearly
-59.49%
Q2 Forecast
117.65

CSL reported $1.23B in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Arca Biopharma USD 2.23M 1.08M Dec/2025
aTyr Pharma USD 82.26M 77.46M Dec/2025
Bio Path USD 199K 300K Sep/2025
Brainstorm Cell Therapeutics USD 1.39M 326K Dec/2025
Cara Therapeutics USD 2.19M 2.45M Sep/2025
CSL USD 1.23B 498M Dec/2025
Curis USD 1.34M 3.45M Dec/2025
Esperion Therapeutics USD 39.42M 456K Dec/2025
Immunic USD 3.45M 451K Dec/2025
Infinity Pharmaceuticals USD 3.75M 2.19M Jun/2023
Minerva Neurosciences USD 2.48M 58.79K Sep/2024
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
TherapeuticsMD USD 1.23M 90K Jun/2024